Fibromyalgia still misunderstood by doctors
A new survey of doctors and fibromyalgia patients reveals the condition severely impacts quality of life and poses a substantial economic burden, a situation which is made worse by a lack of knowledge and understanding on the part of doctors.
The Fibromyalgia Global Impact Survey was developed by the European Network of Fibromyalgia Associations (ENFA), a coalition of patient advocacy organisations, and pharmaceutical firm Pfizer, with the aim of increasing understanding of fibromyalgia and improving diagnosis. The survey involved interviews with a total of 800 fibromyalgia patients and 1,622 doctors from eight countries: the UK, France, Germany, Italy, Spain, the Netherlands, Mexico and South Korea.